[Prognostic significance of minimal residual disease before post-remission therapy in younger adult acute myeloid leukemia patients with intermediate risk and negative of FLT3-ITD, NPM1 and biallelic CEBPA mutations].
作者信息
Zhang Y, Zhang Y M, Zhang Y S, Tang G S, Zhang W P, Yang J M, Wang J M, Hu X X
机构信息
Department of Hematology, Changhai Hospital, the Second Military Medical University; Institute of Hematologic Disease of Chinese PLA, Shanghai 200433, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2019 Jul 14;40(7):597-601. doi: 10.3760/cma.j.issn.0253-2727.2019.07.012.
Abstract
摘要
Zotero 插件